Mark Schmidt

Orcid: 0000-0003-3417-8977

Affiliations:
  • Johnson and Johnson, Janssen Pharmaceutica, Pharmaceutical Research and Development, Beerse, Belgium
  • Novartis Pharma AG, Basel, Switzerland


According to our database1, Mark Schmidt authored at least 5 papers between 2007 and 2021.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [<sup>11</sup>C]-ABP688 PET imaging in healthy volunteers.
NeuroImage, 2021

Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging.
NeuroImage, 2021

2013
Preclinical evaluation of [<sup>18</sup>F]JNJ42259152 as a PET tracer for PDE10A.
NeuroImage, 2013

2010
[18F]JNJ41510417 a potential PET radioligand for imaging phosphodiesterase-10A in the brain.
NeuroImage, 2010

2007
Quantitative evaluation of <sup>11</sup>C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
NeuroImage, 2007


  Loading...